Genetron Holdings (Genetron Holdings) COGS-to-Revenue : 0.59 (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings COGS-to-Revenue?

Genetron Holdings's Cost of Goods Sold for the three months ended in Jun. 2022 was $12.20 Mil. Its Revenue for the three months ended in Jun. 2022 was $20.57 Mil.

Genetron Holdings's COGS to Revenue for the three months ended in Jun. 2022 was 0.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Genetron Holdings's Gross Margin % for the three months ended in Jun. 2022 was 40.72%.

Genetron Holdings COGS-to-Revenue Historical Data

The historical data trend for Genetron Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings COGS-to-Revenue Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

0.55

0.39

0.36

0.57

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
COGS-to-Revenue	Get a 7-Day Free Trial													0.31	0.43	0.44	0.59	-

Genetron Holdings COGS-to-Revenue Calculation

Genetron Holdings's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	52.968	/	93.335
	=	0.57

Genetron Holdings's COGS to Revenue for the quarter that ended in Jun. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	12.196	/	20.574
	=	0.59

Genetron Holdings (NAS:GTH) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Genetron Holdings's Gross Margin % for the three months ended in Jun. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	12.196 / 20.574
	=	40.72 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Genetron Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.